We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WYNN:NASDAQWynn Resorts, Limited Analysis

Data as of 2026-06-22 - not real-time

$105.53

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Wynn Resorts trades just above its 20‑day and 50‑day SMAs, indicating short‑term momentum, while the 200‑day SMA remains higher, keeping the longer‑term bias neutral. RSI is in the mid‑50s, suggesting no overbought pressure, and the MACD line sits above its signal with a modest bullish histogram. Volume is increasing, supporting the price move, but 30‑day volatility exceeds 30% and beta hovers around 1, highlighting market‑wide risk.
Fundamentally, revenue grew nearly 10% YoY with a strong 68% gross margin and an operating margin near 15%. The forward PE of roughly 20 versus a trailing PE of 30 implies valuation compression ahead, and analysts project a median target of $136, translating to about 28% upside. The balance sheet is heavily leveraged, with debt over $12 B and a negative book value per share, raising concerns for dividend durability, though free cash flow remains positive and the dividend payout is modest at under 1% yield. Taken together, the stock offers attractive upside for investors comfortable with the cyclical and regulatory environment of the casino industry.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover
  • Increasing trading volume
  • Proximity to near‑term resistance with upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst median target price implying ~28% upside
  • Solid revenue growth and high gross margins
  • Modest dividend and positive free cash flow

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage and negative book value
  • Cyclical nature of the casino industry
  • Regulatory and geographic exposure in multiple jurisdictions

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin5.14%
P/E Ratio30.2
ROA5.60%
P/B Ratio-39.3
Op. Cash Flow$1.4B
Free Cash Flow$356.9M

Technical Analysis

TrendNeutral
RSI54.3
Support$95.43
Resistance$111.29
MA 20$103.59
MA 50$103.48
MA 200$113.90
MACDBullish
VolumeIncreasing
Fear & Greed Index90.61

Valuation

Target Price$135.89
Upside/Downside28.77%
GradeUndervalued
TypeBlend
Dividend Yield0.95%

Risk Assessment

Beta1.00
Volatility33.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.